Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group.

N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.

PMID:
28910237
2.

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.

N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.

PMID:
28605603
3.

Reduction of SPECT MPI Radiation Dose Using Contemporary Protocols and Technology.

Thompson RC, O'Keefe JH, McGhie AI, Bybee KA, Thompson EC, Bateman TM.

JACC Cardiovasc Imaging. 2017 May 2. pii: S1936-878X(17)30343-1. doi: 10.1016/j.jcmg.2017.03.008. [Epub ahead of print] No abstract available.

PMID:
28495023
4.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

5.

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR; EUCLID Trial Steering Committee and Investigators.

N Engl J Med. 2017 Jan 5;376(1):32-40. doi: 10.1056/NEJMoa1611688. Epub 2016 Nov 13.

6.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators.

N Engl J Med. 2016 Nov 10;375(19):1834-1844. Epub 2016 Sep 15.

7.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

8.

Matters of the heart: cardiovascular disease in U.S. women.

Bybee KA, Stevens TL.

Mo Med. 2013 Jan-Feb;110(1):65-70. Review.

PMID:
23457755
9.

Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.

Thompson RC, Patil H, Thompson EC, Thomas GS, Al-Amoodi M, Kennedy KF, Bybee KA, Iain McGhie A, O'Keefe JH Jr, Oakes L, Bateman TM.

J Nucl Cardiol. 2013 Apr;20(2):214-21; quiz 222-6. doi: 10.1007/s12350-012-9660-4. Epub 2012 Dec 12.

PMID:
23233371
10.

ST-segment elevation: defined by the company it keeps.

O'Keefe JH, Bybee KA, Lavie CJ, Hammill SC.

Mayo Clin Proc. 2012 Jul;87(7):610-3. doi: 10.1016/j.mayocp.2012.05.003. No abstract available.

11.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
12.

Transient apical ballooning and apical sparing variant stress cardiomyopathy in the same patient.

Bhatti SK, Bybee KA, Khalid A, Magalski A, Main ML.

Eur Heart J Cardiovasc Imaging. 2012 Feb;13(2):201. doi: 10.1093/ejechocard/jer247. Epub 2011 Nov 23. No abstract available.

PMID:
22113205
13.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

14.

Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions.

Safley DM, Koshy S, Grantham JA, Bybee KA, House JA, Kennedy KF, Rutherford BD.

Catheter Cardiovasc Interv. 2011 Sep 1;78(3):337-43. doi: 10.1002/ccd.23002. Epub 2011 Mar 16.

PMID:
21413136
15.

Diagnostic and clinical benefit of combined coronary calcium and perfusion assessment in patients undergoing PET/CT myocardial perfusion stress imaging.

Bybee KA, Lee J, Markiewicz R, Longmore R, McGhie AI, O'Keefe JH, Hsu BL, Kennedy K, Thompson RC, Bateman TM.

J Nucl Cardiol. 2010 Apr;17(2):188-96. doi: 10.1007/s12350-009-9159-9. Epub 2009 Dec 11.

PMID:
20012515
16.

Stress cardiomyopathy syndrome: a contemporary review.

Kapoor D, Bybee KA.

Curr Heart Fail Rep. 2009 Dec;6(4):265-71. Review.

PMID:
19948095
17.

Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation.

Abuissa H, O'Keefe JH, Bybee KA.

Clin Cardiol. 2009 Oct;32(10):544-8. doi: 10.1002/clc.20669. Review.

18.

Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias.

Abuissa H, O'Keefe JH, Bybee KA.

Clin Cardiol. 2009 Oct;32(10):549-52. doi: 10.1002/clc.20435. Review.

19.

A longer course of varenicline therapy improves smoking cessation rates.

Lee JH, Jones PG, Bybee K, O'Keefe JH.

Prev Cardiol. 2008 Fall;11(4):210-4. doi: 10.1111/j.1751-7141.2008.00003.x. Review.

20.

Intensive lipid intervention in the post-ENHANCE era.

O'Keefe JH, Bybee KA, Lavie CJ.

Mayo Clin Proc. 2008 Aug;83(8):867-9. doi: 10.4065/83.8.867. No abstract available.

PMID:
18674470

Supplemental Content

Loading ...
Support Center